AGL logo

agilon health inc. (AGL)

$0.66

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on AGL

Market cap

$275680955

EPS

-0.75

P/E ratio

--

Price to sales

0.05

Dividend yield

--

Beta

0.107946

Price on AGL

Previous close

$0.70

Today's open

$0.70

Day's range

$0.63 - $0.73

52 week range

$0.34 - $6.08

Profile about AGL

CEO

Steven J. Sell

Employees

1076

Headquarters

Westerville, OH

Exchange

New York Stock Exchange

Shares outstanding

414869759

Issue type

Common Stock

AGL industries and sectors

Healthcare

Healthcare Providers & Services

News on AGL

Kuehn Law Encourages Investors of Agilon Health, Inc. to Contact Law Firm

NEW YORK, March 5, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Agilon Health, Inc. (NYSE: AGL)  breached their fiduciary duties to shareholders.  According to a federal securities lawsuit, Insiders at Agilon Health caused the company to misrepresent or fail to disclose that: 1) guidance for 2025 was recklessly issued because that they knew or should have known it was not going to be achieved; (2) the immediate positive financial impact from strategic actions taken by Agilon to reduce risk was materially overstated; and (3) as a result, statements about the Company's business, operations, and prospects were materially false and/or misleading at relevant times.

news source

PRNewsWire • 20 hours ago

news preview

AGL Investors Have Opportunity to Lead agilon health, inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES, March 02, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against agilon health, inc. (“Agilon” or “the Company”) (NYSE: AGL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

news source

GlobeNewsWire • Mar 2, 2026

news preview

AGL FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds agilon health (AGL) Investors of Securities Class Action Deadline on March 2, 2026

NEW YORK--(BUSINESS WIRE)---- $AGL #AGL--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against agilon health, inc. (“agilon” or the “Company”) (NYSE: AGL) and reminds investors of the March 2, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has.

news source

Business Wire • Mar 2, 2026

news preview

Portnoy Law Firm Announces Class Action on Behalf of agilon health, inc. Investors

LOS ANGELES, March 02, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises agilon health, inc, (“agilon” or the "Company") (NYSE: AGL) investors off a class action on behalf of investors that bought securities between February 26, 2025 and August 4, 2025, inclusive (the “Class Period”). agilon investors have until March 2, 2026 to file a lead plaintiff motion.

news source

GlobeNewsWire • Mar 2, 2026

news preview

Bronstein, Gewirtz & Grossman LLC Urges agilon health, inc. Investors to Act: Class Action Filed Alleging Investor Harm

NEW YORK, March 02, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against agilon health, inc. (NYSE: AGL) and certain of its officers.

news source

GlobeNewsWire • Mar 2, 2026

news preview

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 2, 2026 in agilon health, inc. Lawsuit – AGL

NEW YORK, March 02, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in agilon health, inc. ("agilon health, inc.

news source

GlobeNewsWire • Mar 2, 2026

news preview

agilon health, inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - AGL

LOS ANGELES, March 2, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against agilon health, inc. (" Agilon" or "the Company") (NYSE: AGL ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

news source

PRNewsWire • Mar 2, 2026

news preview

AGILON CLASS ACTION DEADLINE MARCH 2nd: Bragar Eagel & Squire, P.C. Urgently Reminds Agilon Health Investors with Large Losses to Contact the Firm Before the Lead Plaintiff Deadline

Bragar Eagel & Squire, P.C.  Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Losses In Agilon (AGL) To Contact Him Directly To Discuss Their Options If you purchased or acquired Agilon securities between February 26, 2025 and August 4, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Fortunato directly at (212) 355-4648.

news source

GlobeNewsWire • Mar 1, 2026

news preview

AGL DEADLINE TOMORROW: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages agilon health, inc. Investors 100K to Secure Counsel Before Important March 2 Deadline in Securities Class Action First Filed by the Firm - AGL

New York, New York--(Newsfile Corp. - March 1, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of agilon health, inc. (NYSE: AGL) between February 26, 2025 and August 4, 2025, both dates inclusive (the "Class Period"), of the important March 2, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.

news source

Newsfile Corp • Mar 2, 2026

news preview

AGL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds agilon health (AGL) Investors of Securities Class Action Deadline on March 2, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Agilon health To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Agilon health between February 26, 2025 and August 4, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330  (Ext. 1310). [You may also click here for additional information] NEW YORK, Feb. 28, 2026 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Agilon health, inc.

news source

PRNewsWire • Feb 28, 2026

news preview

¹ Disclosures

Get started with M1

Invest in agilon health inc.

Open an M1 investment account to buy and sell agilon health inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in AGL on M1